Knockout of PRDM1 and NR4A3 improved the anti-tumor response by increasing the generation of long-lived memory cells, counteracting exhaustion in tumor-infiltrating CAR T cells, and enhancing the overall anti-tumor response [207]. Here, NR4A3 is linked to neoplasm.